Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 49 (KRT18P49) is a processed pseudogene derived from the keratin 18 (KRT18) gene family. Pseudogenes like KRT18P49 are nonfunctional, often truncated or lacking regulatory sequences, and do not produce functional proteins. There are numerous such pseudogenes related to the keratin 18 gene scattered throughout the human genome, especially for keratin 8 and keratin 18, and none of these pseudogenes are known to encode active proteins or possess recognized biological or disease roles. KRT18P49 is not considered a therapeutic target, biomarker, or a receptor, and there is no evidence supporting any functional or druggable role for this gene fragment. Explanation: - Keratin 18 pseudogene 49 is classified as a pseudogene—specifically, a *processed pseudogene*, meaning it is an inactive genetic relic of the keratin 18 gene, created through duplication or retrotransposition events. - Recent nomenclature consortia and studies have emphasized that these processed pseudogenes, especially those derived from KRT18, are numerous, dispersed, and do **not** contain intact open reading frames nor protein-coding function. - Unlike the functional keratin 18 gene (**KRT18**), which encodes a cytoskeletal protein involved in epithelial structure, cell signaling, and tumor biology, KRT18P49 and related pseudogenes **do not encode proteins or participate in biological processes**. - No literature describes drug interactions, roles in disease, or utility as a biomarker for KRT18P49, since it is not expressed as a functional molecule in cells. If you require information on the **functional keratin 18 gene/protein (KRT18)**, which is a proper structural protein and has established roles in cell integrity and tumor pathology, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 49 (KRT18P49).